Table 3.
Adverse reactions in the control group
| Adverse reactions | Grading | ||||
|---|---|---|---|---|---|
|
| |||||
| Total Score | Grade 1 | Grade 2 | Grade 3 | Grade 4 | |
| Decreased White Blood Cell Count | 34 | 8 | 19 | 7 | 0 |
| Decreased Neutrophil Count | 32 | 9 | 10 | 12 | 1 |
| Decreased Platelet Count | 14 | 6 | 4 | 3 | 1 |
| Anemia | 19 | 8 | 7 | 4 | 0 |
| Increased Alt | 26 | 13 | 11 | 1 | 1 |
| Increased Ast | 19 | 8 | 9 | 1 | 1 |
| Increased Ggt | 13 | 6 | 3 | 1 | 3 |
| Increased Blood Bilirubin | 13 | 5 | 6 | 2 | 0 |
| Increased Creatinine | 5 | 2 | 2 | 1 | 0 |
| Hyperuricemia | 11 | 6 | 5 | 0 | 0 |
| Upper Respiratory Tract Infection | 8 | 4 | 0 | 3 | 1 |
| Lung Infection | 9 | 5 | 0 | 2 | 2 |
| Agranulocytosis with Fever | 4 | 2 | 0 | 1 | 1 |
| Catheter-Related Infection | 2 | 1 | 0 | 1 | 0 |
| Itching | 6 | 0 | 3 | 3 | 0 |
| Feeling Abnormal | 1 | 1 | 0 | 0 | 0 |
| Fatigue | 11 | 7 | 3 | 1 | 0 |
| Diarrhea | 1 | 0 | 1 | 0 | 0 |
| Thromboembolic Events | 1 | 0 | 1 | 0 | 0 |